Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats

Autores
Vargas, Lorena Alejandra; Pinilla, Oscar Andres; Diaz, Romina Gisel; Sepúlveda, Diana Elizabeth; Swenson, Erik R.; Perez, Nestor Gustavo; Alvarez, Bernardo
Año de publicación
2016
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Background Two potent carbonic anhydrase (CA) inhibitors with widely differing membrane permeability, poorly diffusible benzolamide (BZ), and highly diffusible ethoxzolamide (ETZ) were assessed to determine whether they can reduce cardiac dysfunction in rats subjected to coronary artery ligation (CAL)-induced myocardial infarction. Methods and results Rats with evidence of heart failure (HF) at 32 weeks following a permanent left anterior coronary artery occlusion were treated with placebo, BZ, or ETZ (4 mg kg�day−1) for 4 weeks at which time left ventricular function and structure were evaluated. Lung weight/body weight (LW/BW) ratio increased in CAL rats by 17�1% vs. control, suggesting pulmonary edema. There was a trend for BZ and ETZ to ameliorate the increase in LW/BW by almost 50% (9�5% and 9�8%, respectively, versus CAL) (P=.16, NS). Echocardiographic assessment showed decreased left ventricular midwall shortening in HF rats, 21�1% vs. control 32�1%, which was improved by BZ to 29�1% and ETZ to 27�1%, and reduced endocardial shortening in HF rats 38�3% vs. control 62�1%, partially restored by BZ and ETZ to ~50%. Expression of the hypoxia-inducible membrane-associated CAIX isoform increased by ~60% in HF rat hearts, and this effect was blocked by ETZ. Conclusions We conclude that CAL-induced myocardial interstitial fibrosis and associated decline in left ventricular function were diminished with BZ or ETZ treatment. The reductions in cardiac remodeling in HF with both ETZ and BZ CA inhibitors suggest that inhibition of a membrane-bound CA appears to be the critical site for this protection.
Fil: Vargas, Lorena Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Pinilla, Oscar Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Diaz, Romina Gisel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Sepúlveda, Diana Elizabeth. Universidad Favaloro. Facultad de Medicina. Departamento de Ciencias Básicas de la Patología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Swenson, Erik R.. University of Washington. School of Medicine; Estados Unidos
Fil: Perez, Nestor Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Alvarez, Bernardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Materia
Carbonic Anhydrase Inhibitors
Heart Failure
Intracellular Ph
Myocardial Infarction
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/50094

id CONICETDig_42bcc22aa0a71272bed8b5672ee5dcaf
oai_identifier_str oai:ri.conicet.gov.ar:11336/50094
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in ratsVargas, Lorena AlejandraPinilla, Oscar AndresDiaz, Romina GiselSepúlveda, Diana ElizabethSwenson, Erik R.Perez, Nestor GustavoAlvarez, BernardoCarbonic Anhydrase InhibitorsHeart FailureIntracellular PhMyocardial Infarctionhttps://purl.org/becyt/ford/3.1https://purl.org/becyt/ford/3Background Two potent carbonic anhydrase (CA) inhibitors with widely differing membrane permeability, poorly diffusible benzolamide (BZ), and highly diffusible ethoxzolamide (ETZ) were assessed to determine whether they can reduce cardiac dysfunction in rats subjected to coronary artery ligation (CAL)-induced myocardial infarction. Methods and results Rats with evidence of heart failure (HF) at 32 weeks following a permanent left anterior coronary artery occlusion were treated with placebo, BZ, or ETZ (4 mg kg�day−1) for 4 weeks at which time left ventricular function and structure were evaluated. Lung weight/body weight (LW/BW) ratio increased in CAL rats by 17�1% vs. control, suggesting pulmonary edema. There was a trend for BZ and ETZ to ameliorate the increase in LW/BW by almost 50% (9�5% and 9�8%, respectively, versus CAL) (P=.16, NS). Echocardiographic assessment showed decreased left ventricular midwall shortening in HF rats, 21�1% vs. control 32�1%, which was improved by BZ to 29�1% and ETZ to 27�1%, and reduced endocardial shortening in HF rats 38�3% vs. control 62�1%, partially restored by BZ and ETZ to ~50%. Expression of the hypoxia-inducible membrane-associated CAIX isoform increased by ~60% in HF rat hearts, and this effect was blocked by ETZ. Conclusions We conclude that CAL-induced myocardial interstitial fibrosis and associated decline in left ventricular function were diminished with BZ or ETZ treatment. The reductions in cardiac remodeling in HF with both ETZ and BZ CA inhibitors suggest that inhibition of a membrane-bound CA appears to be the critical site for this protection.Fil: Vargas, Lorena Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; ArgentinaFil: Pinilla, Oscar Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; ArgentinaFil: Diaz, Romina Gisel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; ArgentinaFil: Sepúlveda, Diana Elizabeth. Universidad Favaloro. Facultad de Medicina. Departamento de Ciencias Básicas de la Patología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Swenson, Erik R.. University of Washington. School of Medicine; Estados UnidosFil: Perez, Nestor Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; ArgentinaFil: Alvarez, Bernardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; ArgentinaElsevier Science Inc2016-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/50094Vargas, Lorena Alejandra; Pinilla, Oscar Andres; Diaz, Romina Gisel; Sepúlveda, Diana Elizabeth; Swenson, Erik R.; et al.; Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats; Elsevier Science Inc; Cardiovascular Pathology; 25; 6; 11-2016; 468-4771054-8807CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S105488071630093Xinfo:eu-repo/semantics/altIdentifier/doi/10.1016/j.carpath.2016.08.003info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:14:31Zoai:ri.conicet.gov.ar:11336/50094instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:14:31.967CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
title Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
spellingShingle Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
Vargas, Lorena Alejandra
Carbonic Anhydrase Inhibitors
Heart Failure
Intracellular Ph
Myocardial Infarction
title_short Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
title_full Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
title_fullStr Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
title_full_unstemmed Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
title_sort Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats
dc.creator.none.fl_str_mv Vargas, Lorena Alejandra
Pinilla, Oscar Andres
Diaz, Romina Gisel
Sepúlveda, Diana Elizabeth
Swenson, Erik R.
Perez, Nestor Gustavo
Alvarez, Bernardo
author Vargas, Lorena Alejandra
author_facet Vargas, Lorena Alejandra
Pinilla, Oscar Andres
Diaz, Romina Gisel
Sepúlveda, Diana Elizabeth
Swenson, Erik R.
Perez, Nestor Gustavo
Alvarez, Bernardo
author_role author
author2 Pinilla, Oscar Andres
Diaz, Romina Gisel
Sepúlveda, Diana Elizabeth
Swenson, Erik R.
Perez, Nestor Gustavo
Alvarez, Bernardo
author2_role author
author
author
author
author
author
dc.subject.none.fl_str_mv Carbonic Anhydrase Inhibitors
Heart Failure
Intracellular Ph
Myocardial Infarction
topic Carbonic Anhydrase Inhibitors
Heart Failure
Intracellular Ph
Myocardial Infarction
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.1
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Background Two potent carbonic anhydrase (CA) inhibitors with widely differing membrane permeability, poorly diffusible benzolamide (BZ), and highly diffusible ethoxzolamide (ETZ) were assessed to determine whether they can reduce cardiac dysfunction in rats subjected to coronary artery ligation (CAL)-induced myocardial infarction. Methods and results Rats with evidence of heart failure (HF) at 32 weeks following a permanent left anterior coronary artery occlusion were treated with placebo, BZ, or ETZ (4 mg kg�day−1) for 4 weeks at which time left ventricular function and structure were evaluated. Lung weight/body weight (LW/BW) ratio increased in CAL rats by 17�1% vs. control, suggesting pulmonary edema. There was a trend for BZ and ETZ to ameliorate the increase in LW/BW by almost 50% (9�5% and 9�8%, respectively, versus CAL) (P=.16, NS). Echocardiographic assessment showed decreased left ventricular midwall shortening in HF rats, 21�1% vs. control 32�1%, which was improved by BZ to 29�1% and ETZ to 27�1%, and reduced endocardial shortening in HF rats 38�3% vs. control 62�1%, partially restored by BZ and ETZ to ~50%. Expression of the hypoxia-inducible membrane-associated CAIX isoform increased by ~60% in HF rat hearts, and this effect was blocked by ETZ. Conclusions We conclude that CAL-induced myocardial interstitial fibrosis and associated decline in left ventricular function were diminished with BZ or ETZ treatment. The reductions in cardiac remodeling in HF with both ETZ and BZ CA inhibitors suggest that inhibition of a membrane-bound CA appears to be the critical site for this protection.
Fil: Vargas, Lorena Alejandra. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Pinilla, Oscar Andres. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Diaz, Romina Gisel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Sepúlveda, Diana Elizabeth. Universidad Favaloro. Facultad de Medicina. Departamento de Ciencias Básicas de la Patología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Swenson, Erik R.. University of Washington. School of Medicine; Estados Unidos
Fil: Perez, Nestor Gustavo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
Fil: Alvarez, Bernardo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Investigaciones Cardiovasculares ; Argentina
description Background Two potent carbonic anhydrase (CA) inhibitors with widely differing membrane permeability, poorly diffusible benzolamide (BZ), and highly diffusible ethoxzolamide (ETZ) were assessed to determine whether they can reduce cardiac dysfunction in rats subjected to coronary artery ligation (CAL)-induced myocardial infarction. Methods and results Rats with evidence of heart failure (HF) at 32 weeks following a permanent left anterior coronary artery occlusion were treated with placebo, BZ, or ETZ (4 mg kg�day−1) for 4 weeks at which time left ventricular function and structure were evaluated. Lung weight/body weight (LW/BW) ratio increased in CAL rats by 17�1% vs. control, suggesting pulmonary edema. There was a trend for BZ and ETZ to ameliorate the increase in LW/BW by almost 50% (9�5% and 9�8%, respectively, versus CAL) (P=.16, NS). Echocardiographic assessment showed decreased left ventricular midwall shortening in HF rats, 21�1% vs. control 32�1%, which was improved by BZ to 29�1% and ETZ to 27�1%, and reduced endocardial shortening in HF rats 38�3% vs. control 62�1%, partially restored by BZ and ETZ to ~50%. Expression of the hypoxia-inducible membrane-associated CAIX isoform increased by ~60% in HF rat hearts, and this effect was blocked by ETZ. Conclusions We conclude that CAL-induced myocardial interstitial fibrosis and associated decline in left ventricular function were diminished with BZ or ETZ treatment. The reductions in cardiac remodeling in HF with both ETZ and BZ CA inhibitors suggest that inhibition of a membrane-bound CA appears to be the critical site for this protection.
publishDate 2016
dc.date.none.fl_str_mv 2016-11
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/50094
Vargas, Lorena Alejandra; Pinilla, Oscar Andres; Diaz, Romina Gisel; Sepúlveda, Diana Elizabeth; Swenson, Erik R.; et al.; Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats; Elsevier Science Inc; Cardiovascular Pathology; 25; 6; 11-2016; 468-477
1054-8807
CONICET Digital
CONICET
url http://hdl.handle.net/11336/50094
identifier_str_mv Vargas, Lorena Alejandra; Pinilla, Oscar Andres; Diaz, Romina Gisel; Sepúlveda, Diana Elizabeth; Swenson, Erik R.; et al.; Carbonic anhydrase inhibitors reduce cardiac dysfunction after sustained coronary artery ligation in rats; Elsevier Science Inc; Cardiovascular Pathology; 25; 6; 11-2016; 468-477
1054-8807
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S105488071630093X
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.carpath.2016.08.003
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
application/pdf
application/pdf
dc.publisher.none.fl_str_mv Elsevier Science Inc
publisher.none.fl_str_mv Elsevier Science Inc
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842980776799371264
score 12.993085